A phase I study of weekly dosing of trastuzumab-DM1 (T-DM1) in patients with advanced HER2+breast cancer Meeting Abstract


Authors: Krop, I. E.; Mita, M.; Burris, H. A.; Birkner, M.; Girish, S.; Tibbitts, J.; Holden, S. N.; Lutzker, S. G.; Modi, S.
Abstract Title: A phase I study of weekly dosing of trastuzumab-DM1 (T-DM1) in patients with advanced HER2+breast cancer
Meeting Title: 31st Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 69
Issue: 2 Suppl.
Meeting Dates: 2008 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2009-01-15
Start Page: 243S
Language: English
ACCESSION: ISI:000262583201154
PROVIDER: wos
DOI: 10.1158/0008-5472.SABCS-3136
Notes: --- - Meeting Abstract: 3136 - Suppl. S - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Shanu Modi
    268 Modi